Fusion proteins based upon somatostatin receptors

Details Fusion proteins based upon somatostatin receptors Fusion proteins based upon somatostatin receptors

2007-02-13

2007-02-13

Ketter, James (Department: 1636)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C435S006120, C435S007100

Reexamination Certificate

active

10076267

ABSTRACT:
The present invention is directed to fusion proteins that can be used to assay gene transfer and expression both in vitro and in vivo. The fusion proteins contain a reporter protein, e.g. a somatostatin receptor, fused to a second protein, which may be a protein fusion tag. Alternatively, a fusion protein may be fused to a leader sequence. A leader sequence may localize an expressed protein, e.g. localize a fusion protein to the cell membrane. The invention includes nucleic acids encoding the fusion proteins and methods of assaying for gene expression.

REFERENCES:
patent: 5331094 (1994-07-01), Eppler et al.
patent: 5693679 (1997-12-01), Vincent et al.
patent: 5846819 (1998-12-01), Pausch et al.
patent: 5998154 (1999-12-01), Schonbrunn
patent: 6008012 (1999-12-01), Bergsma et al.
patent: 2001/0029035 (2001-10-01), Eisenhut et al.
patent: 2003/0166061 (2003-09-01), Glucksmann et al.
Koller et al. A generic method fr the production of cell lines expressing high levels of 7 transmission receptors Analytical Biochemistry vol. 250 pp. 51-60 1997.
Ausubel et al. Short Protocols in Molecular Biology 4th Ed. 1999 p. 9-27 and p. 9-31.
Coward et al. Controlling signalling with a specifically designed Gi coupled receptor PNAS Jan. 1998 95:352-357.
Koller et al., “A generic method for the production of cell lines expressing high levels of 7-transmembrane receptors,”Analytical Biochemistry,250:51-60, 1997.
Rogers et al., “Evaluation of a n adenoviral vector encoding a model chimeric receptor as a receptor for imaging gene transfer,”Molecular Therapy,3(5), S57, Abstract No. 156, 2001.
Kundra et al., “Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer,”Journal of Nuclear Medicine, 43: 406-412, 2002.
Praetor et al., “Intracellular traffice of the MHC class 1-like IgG Fc receptor, FcRn, expressed in epithelial MDCK cells,”Journal of Cell Science, 112: 2291-2299, 1999.
Rocheville et al., “Subtypes of the somatostatin receptor assemble as functional homo-and heterodimers,”Journal of Biological Chemistry, 275: 7862-7869, 2000.
Rogers et al., “Gene transfer strategies for improving radiolabeled peptide imaging and therapy,”Quarterly Journal of Nuclear Medicine, 44: 208-223, 2000.
Rogers et al., “In vivo localization of 111IN-DTPA-D-PHE1-Octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector,”Clinical Cancer Res., 5: 383-393, 1999.
Schindler et al., “Immunohistochemical localization of the somatostatin SST-2(A) receptor in the rat brain and spinal cord,”Neuroscience, 76: 225-240, 1997.
Zinn et al., “Noninvasive monitoring of gene transfer using a reporter receptor imaged with high-affinity peptide radiolabeled with 99mTc or 188Re,”Journal of Nuclear Medicine, 41:887-895, 2000.

Affiliated with

Also associated with

Rating

Fusion proteins based upon somatostatin receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fusion proteins based upon somatostatin receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion proteins based upon somatostatin receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3865754